almadengenomics

[almadengenomics]

Almaden Genomics’ g.nome® is the omics data science solution that provides scientists with an end-to-end approach to life sciences discovery.

With g.nome, you can simply: 🔎 Select the right datasets for your research using simple queries. ✏️ Pick one of our pre-built, fully modifiable workflows to get quick results and visualizations. 📊 Dig deeper with associated tertiary analysis for a fuller understanding of underlying factors. g.nome enables you to modify any steps along the way with complete traceability and reproducibility of your results.

[almadengenomics]

Almaden Genomics is excited to welcome Kit Fuhrman to the team as Senior Director of Product Management.

After receiving his PhD in Biomedical Sciences and Immunology from the University of Florida, Kit gathered over nine years of experience in the biotech industry building gene expression tools and spatial biology platforms before joining Almaden. In his free time, Kit enjoys drinking too much coffee and running around San Diego.

[almadengenomics]

BIO International Convention

Almaden team will be attending this year's BIO International Convention and sharing insights about g.nome®, our end-to-end hashtag#omics data science solution that enables scientists to select the right datasets, run pre-built workflows, dig deeper with tertiary analysis, and modify as needed along the way with complete traceability and reproducibility of results.

[almadengenomics]

A Comprehensive Guide to Learn Single-Cell RNA Sequencing

Recognizing the role of scRNA-seq, this list aims to help inform newcomers to omics. Whether you are looking to begin your journey into single-cell analysis, deepen your understanding of scRNA-seq, or stay abreast of the latest tools and techniques, the information should be helpful. 

[almadengenomics]

How to Solve the Biological Research Reproducibility Problem

Scientific research holds the keys to a brighter future. Ideation and innovation are rapidly bringing us closer to breakthroughs in personalized medicine, new cancer therapies, and other genomic discoveries. In the relentless search for scientific advancement, biotech leaders are poised to shape both, the future of their organizations and the trajectory of scientific progress.

[almadengenomics]

CRC Pathway Analysis for Targeted Interventions

Colon cancer stands as a major cause of cancer-related deaths globally, necessitating enhanced diagnostic and therapeutic methods. The variance in patient responses highlights the urgent need for personalized treatment strategies. The study "Multi-omics profiling reveals cellular pathways and functions regulated by ALDH1B1 in colon cancer cells," linked to dataset GSE231706, advances our comprehension of colon cancer's molecular intricacies via ALDH1B1 suppression. This research, which utilizes novel biomarkers and genetic insights, is crucial for advancing personalized medicine by pinpointing specific molecular signatures, thus paving the way for customized treatments that promise to elevate survival rates and patient quality of life. Moreover, the use of the user-friendly, codeless platform g.nome® aims ease biologists ability to discover new targeted therapy pathways.

[almadengenomics]

The Almaden Genomics team participated in the American Association for Cancer Research Annual Meeting. AACR plays a pivotal role in advancing our understanding of cancer and facilitating the exchange of cutting-edge research in the field, and its annual meeting showcases the best cancer science and medicine from institutions worldwide.

[almadengenomics]

Since the first commercial Single-cell RNA sequencing (scRNA-seq) platform became available in 2014, the size of single-cell datasets has expanded significantly. What was once prohibitively expensive – sequencing hundreds of thousands of cells for an experiment – is now common practice.

[almadengenomics]

In celebration of National Intern Day, Almaden Genomics is highlighting some of its summer interns, an impressive group of undergraduate and graduate students who are working across a variety of departments within the company.

Thanks to each of you for your hard work this summer!

[almadengenomics]

Delve into the importance of single-cell discovery, featuring Almaden Genomics' Nora Kearns, Bioinformatics Engineer and single-cell workflow architect, Kit Fuhrman, PhD, Head of Product Development, and Hannah Schuyler, Director of Business Development.

To learn more visit: https://almaden.io/blog/single-cell-mastery-fireside-chat

[almadengenomics]

The Almaden team was at the Bio-IT World Conference and Expo on April 15-17, for our sponsored luncheon presentation, "Accelerating Cancer Drug Discovery: g.nome's Impact on Bioinformatic Insights for Benchtop Scientists". Early decisions during #drugdiscovery determine the success of years down the road after hundreds of millions in expenditure, in this presentation, Dmitrij Frishman, PhD and Samir Courdy share how Almaden's g.nome® platform expedites drug discovery by facilitating intuitive data exploration and swift iteration, specifically in colorectal cancer research.

[almadengenomics]

Join Almaden Genomics and BigOmics Analytics for a webinar showcasing how to streamline your analysis process with the collaboration of g.nome® and Omics Playground.

[almadengenomics]

We are thrilled to announce that Elucidata is partnering with Almaden Genomics, bringing together Polly's data harmonization capabilities with g.nome®. This partnership not only marks a significant advancement in omics data science but also sets a new pace for drug discovery processes. By combining our strengths, we're aiming to smash through the barriers of data silos, ensuring that the insights we generate are not just richer but more actionable. This is about speeding up the journey from research to treatment, ensuring groundbreaking therapies reach patients sooner. We're proud to lead this charge, transforming the landscape of lifesciences. 

[almadengenomics]

David Gascoigne and Kit Fuhrman represented Almaden Genomics at LSXLondon on April 29, on the Mezzanine TechBio Stage about g.nome!

[almadengenomics]

Check our webinar to enhance your knowledge and skills in single-cell RNA sequencing analysis. Learn how to: - Handle Data: Master diverse data types. - Optimize Datasets: Utilize publicly available data from platforms. - Apply Advanced Clustering: Explore Seurat for powerful cell clustering. - Automate Annotation: Discover the ease of cell-type annotation. - Integrate AI: Leverage AI foundation models to revolutionize your analysis.

[almadengenomics]

Every hashtag#omics data analysis solution promises to accelerate discovery. However, the process of implementing a solution can drag on resources and time. The g.nome® platform is a cloud-native solution that can be deployed almost instantaneously. Pre-built workflows, ready-to-use tools, and drag-and-drop functionality enable everyone on the research team to jointly deliver an immediate impact on scientific and therapeutic goals. g.nome dramatically improves and accelerates the process of building and running bioinformatic workflows for immediate impact on goals and a higher probability of success in delivering breakthrough treatments to those in need. Learn more: https://lnkd.in/gbjgGh2D

[almadengenomics]

THE g.nome® Platform

Designed to accommodate scientists of all skill levels by providing a drag-and-drop graphical user interface, g.nome enables diverse, widespread teams to build powerful bioinformatic workflows.